Valuation: Cenra Inc.

Market Cap 4.95B 153M 134M 123M 114M 214M 14.72B 219M 1.47B 580M 7.21B 574M 562M 24.82B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.21B 223M 194M 179M 165M 312M 21.43B 319M 2.14B 844M 10.49B 836M 817M 36.13B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 3.01%
1 day-1.74%
1 week-3.69%
Current month-3.00%
1 month-2.31%
3 months+3.67%
6 months-0.29%
Current year+1.50%
1 week 33.9
Extreme 33.9
35.4
1 month 33.9
Extreme 33.9
35.9
Current year 31.55
Extreme 31.55
36.6
1 year 31.55
Extreme 31.55
36.6
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 2020-11-04
Director of Finance/CFO - 2014-03-06
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2016-05-26
Director/Board Member - 2021-05-20
Chairman - 2020-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-1.74%-3.69%-4.37% - 153M
-0.90%-0.15%+14.11%+81.10% 48.15B
-0.23%-1.65%+67.15%+112.03% 35.59B
-0.76%-1.44%-4.29%+37.63% 11.9B
-0.88%-0.62%+17.31%+89.97% 11.85B
+0.19%+2.87%+34.92%+139.73% 9.31B
+3.37%-0.10%+51.64%-3.75% 7.02B
-0.75%-0.91%+17.45%+37.70% 6.91B
-2.25%-2.08%+0.45%+209.99% 6.55B
-9.93%+0.35%-31.51%+16.58% 6.13B
Average -1.39%-0.24%+16.29%+80.11% 14.36B
Weighted average by Cap. -0.88%-0.43%+26.75%+86.59%

Financials

2024 2025
Net sales 8.92B 275M 241M 222M 205M 386M 26.5B 394M 2.65B 1.04B 12.98B 1.03B 1.01B 44.69B 8.57B 264M 231M 213M 197M 371M 25.47B 379M 2.55B 1B 12.47B 993M 971M 42.94B
Net income 317M 9.79M 8.56M 7.9M 7.28M 13.72M 943M 14.02M 94.39M 37.13M 462M 36.78M 35.97M 1.59B 300M 9.26M 8.09M 7.47M 6.88M 12.97M 892M 13.26M 89.25M 35.1M 437M 34.77M 34.01M 1.5B
Net Debt 2.46B 75.82M 66.26M 61.14M 56.36M 106M 7.3B 109M 731M 287M 3.58B 285M 279M 12.31B 2.26B 69.64M 60.85M 56.15M 51.76M 97.56M 6.71B 99.72M 671M 264M 3.28B 262M 256M 11.31B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
26-07-17 NT$33.90 -1.74% 193,666
26-07-16 NT$34.50 -0.86% 81,771
26-07-15 NT$34.80 +0.58% 127,240
26-07-14 NT$34.60 -1.00% 251,470
26-07-13 NT$34.95 -0.71% 146,980
  1. Stock Market
  2. Stocks
  3. 3716 Stock